Cancer Cell
Volume 18, Issue 3, 14 September 2010, Pages 220-230
Journal home page for Cancer Cell

Article
A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor Development

https://doi.org/10.1016/j.ccr.2010.07.010Get rights and content
Under an Elsevier user license
open archive

Summary

MDM2, a negative regulator of p53, is elevated in many cancers that retain wild-type p53. A single nucleotide polymorphism (SNP) in the human MDM2 promoter increases the affinity of Sp1 resulting in elevated MDM2 levels. We generated mice carrying either the MDM2SNP309T or the MDM2SNP309G allele to address the impact of MDM2SNP309G on tumorigenesis. Mdm2SNP309G/G cells exhibit elevated Mdm2 levels, reduced p53 levels, and decreased apoptosis. Importantly, some Mdm2SNP309G/G mice succumbed to tumors before 1 year of age, suggesting that this allele increases tumor risk. Additionally, the Mdm2SNP309G allele potentiates the tumor phenotype and alters tumor spectrum in mice inheriting a p53 hot-spot mutation. These data provide causal evidence for increased cancer risk in carriers of the Mdm2SNP309G allele.

Highlights

► A nucleotide polymorphism in the MDM2 promoter has been associated with cancer risk ► Clinical data attempting to link this SNP to cancer risk has been controversial ► We have generated mice carrying these polymorphic MDM2SNP309 alleles ► The Mdm2SNP309G allele directly results in an increased cancer risk

Cited by (0)